Chemotherapy following radium-223 dichloride treatment in ALSYMPCA

Sartor, O., Hoskin, P., Coleman, R.E. orcid.org/0000-0002-4275-1043 et al. (6 more authors) (2016) Chemotherapy following radium-223 dichloride treatment in ALSYMPCA. Prostate, 76 (10). pp. 905-916. ISSN 0270-4137

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 The Authors. The Prostate published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: radium-223; prostate; chemotherapy; safety; alpha emitter; bone
Dates:
  • Published: 1 July 2016
  • Accepted: 1 March 2016
  • Published (online): 23 March 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 11 Jul 2016 15:38
Last Modified: 11 Jul 2016 15:43
Published Version: http://dx.doi.org/10.1002/pros.23180
Status: Published
Publisher: John Wiley & Sons
Refereed: Yes
Identification Number: https://doi.org/10.1002/pros.23180

Share / Export

Statistics